| MEDI | Monday, September 8, 2003 | ||
1:30 PM-5:10 PM Sheraton New York -- Royal Ballroom A,Oral | |||
Role of Organic Synthesis in Early Clinical Drug Development | |||
| Organizer, Presiding: | Stephane Caron | ||
| 1:30 PM | 36 | Introductory Remarks: Recent changes in early development environment Stephane Caron | |
| 1:40 PM | 37 | Development and optimization of the asymmetric synthesis of ABT-100 Albert W. Kruger, Michael J. Rozema, Bridget D. Rohde, James Jien-Heh Tien, Weijiang Zhang, Lakshmi Bhagavatula, Bhadra Shelat | |
| 2:20 PM | 38 | Practical synthesis of cell adhesion inhibitors via crystallization-driven dynamic transformations Nathan K. Yee, Magnus Eriksson, Vittorio Farina, Rogelio P. Frutos, Suresh Kapadia, Elio Napolitano | |
| 3:00 PM | 39 | Large-scale synthesis of cryptophycin 52 (LY355703) James A. Aikins, Tony Zhang, Takia Oglesby | |
| 3:40 PM | 40 | Asymmetric hydrogenation: A new process to Pregabalin William S. Kissel | |
| 4:20 PM | 41 | Development of carbo- and heterocyclizations: Application to a practical synthesis of the Cox-II specific inhibitor Etoricoxib Jean-Francois Marcoux | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
The 226th ACS National Meeting, New York, NY, September 7-11, 2003